REGENERON PHARMACEUTICALS, INC. reports material agreement in SEC 8-K

REGENERON PHARMACEUTICALS, INC. filed an 8-K covering a material definitive agreement, results of operations or financial condition, and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.